BridgeMD
New treatment option for Infertility Assisted Reproductive Technology
Official title The Feasibility of taVNS on Pregnancy Outcomes of Infertility Patients Undergoing IVF
ClinicalTrials.gov ID: NCT06742788
What this study is testing
- What it's testing
- To assess the feasibility of taVNS on pregnancy outcomes of infertility subjects undergoing IVF, the primary aim of this trial will focus on encompassing recruitment, compliance, and preliminary engagement outcomes. The exploratory aim is to carry out clinical research, which entails evaluating the preliminary effects of the intervention in order to ascertain its potential benefits.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 40
You may be able to join if
- people aged 20 to 40 years, diagnosed with infertility, and preparing to undergo IVF treatment;
- Female people with anti-Müllerian hormone (AMH) \> 1.2 ng/mL;
- Scoring at mild-to-moderate levels of impairment on anxiety, and depression scales;
- Both the subject and their family sign the informed consent form.
You likely can't join if
- The subject had been treated with taVNS in the past;
- people preparing to undergo frozen embryo transfer;
- people with a history of mental disorder or who score at a severe level of impairment on anxiety and depression scales;
- Taking sedatives, anxiety, depression, or psychiatric medications;
- Comorbidities including arrhythmia, hypertension, diabetes, chronic heart and kidney diseases;
- Ineligibility for enrollment assessed by a gynecologist or neurologist;
See the full eligibility criteria
- people aged 20 to 40 years, diagnosed with infertility, and preparing to undergo IVF treatment;
- Female people with anti-Müllerian hormone (AMH) \> 1.2 ng/mL;
- Scoring at mild-to-moderate levels of impairment on anxiety, and depression scales;
- Both the subject and their family sign the informed consent form.
- The subject had been treated with taVNS in the past;
- people preparing to undergo frozen embryo transfer;
- people with a history of mental disorder or who score at a severe level of impairment on anxiety and depression scales;
- Taking sedatives, anxiety, depression, or psychiatric medications;
- Comorbidities including arrhythmia, hypertension, diabetes, chronic heart and kidney diseases;
- Ineligibility for enrollment assessed by a gynecologist or neurologist;
- Metallic implants or devices contraindicating taVNS.
The study team makes the final eligibility decision.
Where it's taking place
- Xi'an, Shaanxi, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Xi'an, Shaanxi, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.